Healthcare and life sciences are about to face unprecedented AI-driven regulatory changes that will reshape everything from research and development to drug approval submissions. Here are 10 steps healthcare and life sciences organizations should take to strategically prepare. The post White House AI Action Plan: What Healthcare Leaders Must Do Now appeared first on MedCity…
[Sponsored] Clinical Architecture Founder and CEO Charlie Harp talked about how clinical data can be assessed and improved to build trust from the healthcare industry. The post The Future of AI in Healthcare Depends on Clinical Data Quality Assessment appeared first on MedCity News.
As Health and Human Services Secretary Robert F. Kennedy Jr.’s dismantling of federal vaccine policy continues to roil the Centers for Disease Control and Prevention, some Democratic-led states have struck out on their own, setting up new systems to help them assess the science and maintain immunization access for their residents. Four western states —…
Tamir Gottfried, the Chief Commercial and Strategy Officer at TytoCare came on THCB to show us how their remote device works to deliver the last few inches of telehealth. Most telehealth is just a video call but with Tyto’s device, the patient can asynchronously (and/or synchronously) take their vital signs including videos and pictures of…
Digital health funding remains strong so far this year, with $9.9 billion raised through Q3 and megarounds driving record deal sizes. However, the path to scale is becoming less predictable, as startups increasingly rely on unlabeled rounds and face longer timelines to reach Series B. The post Inside a Big Q3: Venture Capital for Digital…
CertifyOS launched Provider Hub, an AI-powered platform that helps payers unify provider data and reduce administrative costs. The post CertifyOS Unveils Provider Data Platform to Streamline Operations and Cut Costs appeared first on MedCity News.
Hours into the federal government shutdown, Julio Fuentes stood steps from the U.S. Capitol to deliver an urgent message about the Hispanic voting bloc that helped the GOP sweep into power last year. Those votes, he cautioned, are at risk if Congress doesn’t pass a law to preserve lower premiums on Affordable Care Act marketplace…
While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug’s potential to be combined with Novo Nordisk’s Wegovy. Skye’s drug is an antibody designed to preferentially target CB1 receptors in the gut, offering an alternative approach to activating GLP-1…
Horas después del cierre del gobierno federal, Julio Fuentes se encontraba a pocos pasos del Capitolio de Estados Unidos para transmitir un mensaje urgente sobre el bloque de votantes hispanos que ayudó al Partido Republicano a llegar al poder el año pasado. Esos votos, advirtió, están en riesgo si el Congreso no aprueba una ley…
Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it. The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.